Delivery Order SPE2DB24D9228-SPE2DB26FATEL

The Defense Logistics Agency awarded a delivery order valued at $16,701.30 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in one-dose vials. The award was issued on October 16, 2025, with an ultimate completion date of November 6, 2025, under firm fixed-price terms with no set-aside designation. This delivery order represents one of numerous recent awards issued to DMS Pharmaceutical Group by the Defense Logistics Agency's Medical Supply Chain division, demonstrating the vendor's established capability to supply critical pharmaceutical products to Department of Defense healthcare operations.

This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to establish multiple regional prime vendors for recurring medical supply needs of military healthcare facilities worldwide. The parent IDC, designated SPE2DR and awarded on November 13, 2025, carries a ceiling value of $499,999,999 and extends through December 31, 2036, with a 30-month base period and three optional 30-month renewal periods. DMS Pharmaceutical Group's performance across its diverse product portfolio—spanning vaccines, biologics, specialty pharmaceuticals, and medical consumables—positions the company as a critical supplier within the federal military pharmaceutical supply chain.